Enzo Biochem, Inc. (NYSE: ENZ) reported Q4 EPS of ($0.69), versus ($0.11) reported last year. Revenue for the quarter came in at $26.4 million, versus $26.8 million reported last year.

For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.

Earnings